Hyperhydration with cisplatin does not influence pemetrexed exposure

Pemetrexed is a cytotoxic drug for first‐line treatment of lung cancer. It is often combined with other anticancer drugs such as cisplatin or carboplatin. In clinical practice, hyperhydration regimens are applied to overcome cisplatin‐related nephrotoxicity. As pemetrexed is almost completely elimin...

Descripción completa

Detalles Bibliográficos
Autores principales: de Rouw, Nikki, Derijks, Hieronymus J., Hilbrands, Luuk B., Boosman, René J., Piet, Berber, Koolen, Stijn L. W., Burgers, Jacobus A., Dingemans, Anne‐Marie C., van den Heuvel, Michel M., Hendriks, Lizza E. L., Aerts, Joachim G. J. V., Croes, Sander, Mathijssen, Ron H. J., Huitema, Alwin D. R., Burger, David M., Biesma, Bonne, ter Heine, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290918/
https://www.ncbi.nlm.nih.gov/pubmed/34374116
http://dx.doi.org/10.1111/bcp.15031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290918/
https://www.ncbi.nlm.nih.gov/pubmed/34374116
http://dx.doi.org/10.1111/bcp.15031

Ejemplares similares